Gilead Sciences Inc on Wednesday said its experimental antiviral drug remdesivir helped improve outcomes for patients with COVID-19, and provided data suggesting it worked better when given earlier in the course of infection.
FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam/
Results from that trial have been highly anticipated because it compares how patients who received remdesivir fared versus patients who did not. The lead researcher on that trial told Reuters on Friday that results could come by mid-May, with preliminary findings possible even earlier.Gilead also provided data on a study that it has conducted in dozens of medical centers, which does not compare the use of remdesivir against a placebo.
“The study demonstrates the potential for some patients to be treated with a five-day regimen, which could significantly expand the number of patients who could be treated with our current supply of remdesivir,” said Merdad Parsey, chief medical officer at Gilead Sciences, in a statement.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Gilead Sciences says there are 'positive data' from a study on possible Covid-19 treatment remdesivirThere's 'positive data' emerging from a study on possible Covid-19 treatment remdesivir, the maker of the investigational drug says
続きを読む »
Study Shows Shorter Course of Gilead Drug as Effective Against Covid-19Gilead Sciences said its phase 3 study for the antiviral remdesivir demonstrated that patients with severe Covid-19 taking the drug over a five-day treatment had similar improvement compared with those taking the 10-day course.
続きを読む »
COVID-19 treatment yields disappointing data in trial and shows it’s not easy to develop drugsA disappointing set of data from Regeneron Pharmaceuticals Inc. and Sanofi’s mid-stage clinical trial testing Kevzara as a COVID-19 treatment underscores the...
続きを読む »
Global arms spending is rising, but covid-19 will trim budgetsAmerica’s military spending is almost two-fifths of the world’s total and more than the next ten countries combined
続きを読む »
The Secret Group of Scientists and Billionaires Pushing a Manhattan Project for Covid-19They are working to cull the world’s most promising research on the pandemic, passing on their findings to policy makers and the White House.
続きを読む »
War-hit Yemen struggles to trace Covid-19 infectionSplit into rival power centres, its medical infrastructure shattered by war and seen by the United Nations as the world's worst humanitarian crisis, Yemen is handicapped by its own destitution in its fight against the new coronavirus.
続きを読む »